In close collaboration with Oslo University Hospital and its Norwegian and European partners, DNV Imatis will over the next three years develop and implement innovative digital patient-centered care pathways for cancer patients. The project has been named MyPath.
Published June 29, 2022, 2:27 pm
The challenges in cancer care are expected to increase as new anticancer treatments and expectations of shared decision-making in the society call for improved patient-centered cancer care. Modern cancer treatment requires a close interaction between tumor-oriented and patient-centered treatment. Through the MyPath project, DNV Imatis will develop and implement the digital patient – centered pathways of the future for cancer patients. Digital communication with the patients about their ailments and needs, where they will be asked and involved, among other things, using digital questionnaires. This can be done both at home and in the hospital. The purpose is to contribute to the design of individual plans for the individual patient, continuous active participation, less pain, better physical and mental function, and improvement of the overall quality of life. A significant improvement in the working life of health personnel is also expected in that their resources will be used more cost-effectively.
The overall goal is for patients to be heard and at the same time be actively involved in planning and decisions about their own treatment. MyPath will develop completely new methods that can be implemented both in Norway and eight other countries in Europe. This is made possible through a significant amount of support of 60MNOK in funds from the EU.
MyPath will be based on DNV Imatis ‘digital platform and OUS’ many years of experience in development and research on patient processes, together with some of the leading researchers in the world. Together, the actors form the basis for the development of the digital solutions that will take place with the active involvement of patients, healthcare professionals, researchers and ICT developers. “In the course of two years, we will have the solutions needed to be able to implement MyPath in the daily cancer treatment, both at a national and international level.”
DNV has entered partnership with the Norwegian Cancer Society
The agreement is based on an intention of active cooperation and commitment, where the parties together will create results in research and development projects, share expertise and to create commitment among employees for the cancer cause. The purpose of the agreement is for the parties together to create value and positive change for the health sector, as well as increase the pace and increase the pace of innovation for the benefit of the cancer cause. The parties shall open doors to each other. Furthermore, the collaboration will contribute to increased competence, knowledge sharing and innovation in health technology through DNV’s technology and data competence, the Norwegian Cancer Society’s competence on the cancer issue and the Norwegian Cancer Society’s network and users. The collaboration will also lead to a positive attitude creation and commitment to the Cancer Case.